News

Innovative Health Initiative: updated Guide for Applicants + Platform for ideas for future topics

Published on | 3 years ago

Programmes Health

The Innovative Health Initiative (IHI) informs potential applicants that the updated version of the Guide for Applicants has been published here. The update includes additional text concerning the Right to Object and the 45% threshold related to the contribution from private members.


IHI also informs that the webpage and the platform for collecting ideas for potential IHI topics are now online. The webpage including the online form to submit ideas is available on IHI website here. The aim is to collect ideas from a wide range of stakeholders, to help IHI define its annual scientific priorities and areas for future calls for proposals.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1772 articles available search in articles 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.